Matthew C. Altman

Matthew C. Altman

Auto-generated profile, based on publicly available information

Matthew C. Altman

Benaroya Research Institute, Seattle, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MAMatthew C. Altman
Matthew C. Altman
MGMichelle A. Gill
Michelle A. Gill
EWElizabeth Whalen
Elizabeth Whalen
DBDenise C. Babineau
Denise C. Babineau
BSBaomei Shao
Baomei Shao
DJDaniel J. Jackson
Daniel J. Jackson

4 January 2023 in The Lancet Planetary Health
Verified
Journal Article
Open access
MAMatthew C Altman
Matthew C Altman
MKMeyer Kattan
Meyer Kattan
GOGeorge T O'COnnor
George T O'COnnor
RMRyan C Murphy
Ryan C Murphy
EWElizabeth Whalen
Elizabeth Whalen
DJDaniel J Jackson
Daniel J Jackson
Asthma prevalence and severity have markedly increased with urbanisation, and children in low-income urban centres have among the greatest asthma morbidity. Outdoor air pollution has been associated with adverse respiratory effects in children with asthma. However, the mechanisms by which air pollution exposure exacerbates asthma, and how these mechanisms compare with exacerbations induced by respiratory viruses, are poorly understood. We aimed to investigate the associations between regional air pollutant concentrations, respiratory illnesses, lung function, and upper airway transcriptional signatures in children with asthma, with particular focus on asthma exacerbations occurring in the absence of respiratory virus. We performed a retrospective analysis of data from the MUPPITS1 cohort and validated our findings in the ICATA cohort. The MUPPITS1 cohort recruited 208 children aged 6-17 years living in urban areas across nine US cities with exacerbation-prone asthma between Oct 7, 2015, and Oct 18, 2016, and monitored them during reported respiratory illnesses. The last MUPPITS1 study visit occurred on Jan 6, 2017. The ICATA cohort recruited 419 participants aged 6-20 years with persistent allergic asthma living in urban sites across eight US cities between Oct 23, 2006, and March 25, 2008, and the last study visit occurred on Dec 30, 2009. We included participants from the MUPPITS1 cohort who reported a respiratory illness at some point during the follow-up and participants from the ICATA cohort who had nasal samples collected during respiratory illness or at a scheduled visit. We used air quality index values and air pollutant concentrations for PM2·5, PM10, O3, NO2, SO2, CO, and Pb from the US Environmental Protection Agency spanning the years of both cohorts, and matched values and concentrations to each illness for each participant. We investigated the associations between regional air pollutant concentrations and respiratory illnesses and asthma exacerbations, pulmonary function, and upper airway transcriptional signatures by use of a combination of generalised additive models, case crossover analyses, and generalised linear mixed-effects models. Of the 208 participants from the MUPPITS1 cohort and 419 participants from the ICATA cohort, 168 participants in the MUPPITS1 cohort (98 male participants and 70 female participants) and 189 participants in the ICATA cohort (115 male participants and 74 female participants) were included in our analysis. We identified that increased air quality index values, driven predominantly by increased PM2·5 and O3 concentrations, were significantly associated with asthma exacerbations and decreases in pulmonary function that occurred in the absence of a provoking viral infection. Moreover, individual pollutants were significantly associated with altered gene expression in coordinated inflammatory pathways, including PM2·5 with increased epithelial induction of tissue kallikreins, mucus hypersecretion, and barrier functions and O3 with increased type-2 inflammation. Our findings suggest that air pollution is an important independent risk factor for asthma exacerbations in children living in urban areas and is potentially linked to exacerbations through specific inflammatory pathways in the airway. Further investigation of these potential mechanistic pathways could inform asthma prevention and management approaches. National Institutes of Health, National Institute of Allergy and Infectious Diseases.

14 October 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MAMatthew C. Altman
Matthew C. Altman
YLYing Lai
Ying Lai
JNJames D. Nolin
James D. Nolin
SLSydney Long
Sydney Long
CCChien-Chang Chen
Chien-Chang Chen
THTeal S. Hallstrand
Teal S. Hallstrand
Asthma is a heterogeneous syndrome that has been subdivided into physiological phenotypes and molecular endotypes. The most specific phenotypic manifestation of asthma is indirect airway hyperresponsiveness (AHR), and a prominent molecular endotype is the presence of type-2 inflammation. The underlying basis for type-2 inflammation and its relationship to AHR are incompletely understood. We assessed the expression of type-2 cytokines in the airways of subjects with and without asthma who were extensively characterized for AHR. Using quantitative morphometry of the airway wall, we identified a shift in mast cells from the submucosa to the airway epithelium specifically associated with both type-2 inflammation and indirect AHR. Using ex vivo modeling of primary airway epithelial cells in organotypic co-culture with mast cells, we have shown that epithelial-derived IL-33 uniquely induced type-2 cytokines in mast cells, which regulated the expression of epithelial IL33 in a feedforward loop. This feedforward loop was accentuated in epithelial cells derived from subjects with asthma. These results demonstrate that type-2 inflammation and indirect AHR in asthma are related to a shift in mast cell infiltration to the airway epithelium, and that mast cells cooperate with epithelial cells through IL-33 signaling to regulate type-2 inflammation.

19 July 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MAMatthew C. Altman
Matthew C. Altman
DRDarawan Rinchai
Darawan Rinchai
NBNicole Baldwin
Nicole Baldwin
MTMohammed Toufiq
Mohammed Toufiq
EWElizabeth Whalen
Elizabeth Whalen
DCDamien Chaussabel
Damien Chaussabel
As the capacity for generating large-scale molecular profiling data continues to grow, the ability to extract meaningful biological knowledge from it remains a limitation. Here, we describe the development of a new fixed repertoire of transcriptional modules, BloodGen3, that is designed to serve as a stable reusable framework for the analysis and interpretation of blood transcriptome data. The construction of this repertoire is based on co-clustering patterns observed across sixteen immunological and physiological states encompassing 985 blood transcriptome profiles. Interpretation is supported by customized resources, including module-level analysis workflows, fingerprint grid plot visualizations, interactive web applications and an extensive annotation framework comprising functional profiling reports and reference transcriptional profiles. Taken together, this well-characterized and well-supported transcriptional module repertoire can be employed for the interpretation and benchmarking of blood transcriptome profiles within and across patient cohorts. Blood transcriptome fingerprints for the 16 reference cohorts can be accessed interactively via: https://drinchai.shinyapps.io/BloodGen3Module/.

10 March 2021 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MAMatthew C. Altman
Matthew C. Altman
ACAgustin Calatroni
Agustin Calatroni
SRSima Ramratnam
Sima Ramratnam
DJDaniel J. Jackson
Daniel J. Jackson
SPScott Presnell
Scott Presnell
JGJames E. Gern
James E. Gern

8 February 2022 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
KMKathryn E. McCauley
Kathryn E. McCauley
KFKaitlin Flynn
Kaitlin Flynn
ACAgustin Calatroni
Agustin Calatroni
VDVincent DiMassa
Vincent DiMassa
BLBrandon LaMere
Brandon LaMere
SLSusan V. Lynch
Susan V. Lynch